Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.

Di J, Zheng B, Kong Q, Jiang Y, Liu S, Yang Y, Han X, Sheng Y, Zhang Y, Cheng L, Han J.

Mol Oncol. 2019 Aug 13. doi: 10.1002/1878-0261.12564. [Epub ahead of print]


An Analytical Review of Computational Drug Repurposing.

Sadeghi SS, Keyvanpour MR.

IEEE/ACM Trans Comput Biol Bioinform. 2019 Aug 12. doi: 10.1109/TCBB.2019.2933825. [Epub ahead of print]


Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals.

Zarros A, Tansey T.

Front Pharmacol. 2019 Jul 25;10:834. doi: 10.3389/fphar.2019.00834. eCollection 2019. No abstract available.


The in vitro antibacterial activity of the anthelmintic drug oxyclozanide against common small animal bacterial pathogens.

Levinson MR, Blondeau JM, Rosenkrantz WS, Plowgian CB.

Vet Dermatol. 2019 Aug;30(4):314-e87. doi: 10.1111/vde.12755. Epub 2019 May 7.


Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments.

Sales TA, Prandi IG, Castro AA, Leal DHS, Cunha EFFD, Kuca K, Ramalho TC.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1829. doi: 10.3390/ijms20081829. Review.


A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.

Delerue T, Tribouillard-Tanvier D, Daloyau M, Khosrobakhsh F, Emorine LJ, Friocourt G, Belenguer P, Blondel M, Arnauné-Pelloquin L.

Dis Model Mech. 2019 Feb 7;12(2). pii: dmm036558. doi: 10.1242/dmm.036558.


Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

Ananthula HK, Parker S, Touchette E, Buller RM, Patel G, Kalman D, Salzer JS, Gallardo-Romero N, Olson V, Damon IK, Moir-Savitz T, Sallans L, Werner MH, Sherwin CM, Desai PB.

BMC Pharmacol Toxicol. 2018 Dec 4;19(1):80. doi: 10.1186/s40360-018-0270-x.

Supplemental Content

Loading ...
Support Center